REYKJAVIK, Iceland – Scientists at deCODE Genetics and academic collaborators from Iceland, Norway, Denmark, the Netherlands and the USA today report the discovery of low frequency variants in the human genome that associate with risk of gout, a common inflammatory arthritis, and serum uric acid levels. The study was done in collaboration with Illumina, Inc., […]
La Jolla, CA – Prognosys Biosciences® is pleased to announce Voila!™, a new cloud-based data analysis service for next-generation sequencing data. Voila! will be available initially for RNA sequencing projects that utilize data from Illumina® HiSeq and GAIIx next-generation sequencing instruments. Researchers working with RNA sequencing data face many analysis challenges, ranging from the size […]
Illumina, Inc. today announced estimated third quarter revenue of approximately $235 million. This estimate is based on management’s preliminary financial review and remains subject to review by our independent registered public accounting firm. We currently believe the following factors negatively affected our revenue in the third quarter compared to our forecast: Continued uncertainty surrounding the […]
Illumina, Inc. today announced it has entered into a wide-ranging collaborative research agreement with the Institute of Applied Genetics and the Department of Forensic and Investigative Genetics at the University of North Texas Health Science Center (UNTHSC). Illumina and UNTHSC will collaborate on several visionary projects in forensics using Illumina’s next-generation sequencing technologies. The goals […]
MENLO PARK, Calif.–Pacific Biosciences of California, Inc., provider of Single Molecule Real Time (SMRT®) sequencing products, today announced the appointment of Michael J. Glynn as Chief Commercial Officer. Michael Glynn has more than 40 years of experience in global commercial operations. Prior to joining Pacific Biosciences, Mr. Glynn served as Regional President, Japan – Asia […]
MOUNTAIN VIEW, Calif. and LA JOLLA, Calif. — Complete Genomics Inc., the whole human genome sequencing company, and the not-for-profit Scripps Health system today announced a major collaboration that will help further the Wellderly Study, a landmark scientific research initiative aimed at unlocking the genetic secrets of lifelong health. Under the collaboration, Complete Genomics will […]
HELSINKI, Finland – MediSapiens Ltd, a Finnish bioinformatics company, has released the most comprehensive map of human gene expression yet for public use. The data is available through a graphical tool, Transcriptome Viewer, at the home page of MediSapiens Ltd, allowing exploration of the expression activity of genes across chromosomes in tens of healthy human […]
ALISO VIEJO, Calif. — Ambry Genetics today announces that it is the first laboratory to provide CLIA-approved exome services for applications in clinical diagnostics. After comprehensive review by Ambry’s staff of geneticists and medical directors, these results will allow clinicians to diagnose affected patients with conditions that have eluded traditional diagnostic approaches. As part of […]
SAN CARLOS, Calif. and SAN DIEGO — Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced it has signed a three-year supply agreement with Illumina, Inc., a leading developer and manufacturer of life sciences tools for the large-scale analysis of genetic variation and function. Under the terms of the agreement, […]
At the “NGx: Evolution of Next Generation Sequencing” conference in Providence, Rhode Island, CLC bio and BIOBASE together launched a new plug-in for CLC bio’s new framework for visualizing, combining and analyzing genome data, Genomics Gateway, which integrates the human-curated biological databases contained in BIOBASE’s Genome Trax™, including TRANSFAC® and HGMD® Professional. COO at BIOBASE, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
